Anfield Announces Shareholder Approval of Sale of Mayaniquel S.A. to Cunico Resources N.V.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jun 13, 2014) - Anfield Nickel Corp. ("Anfield") (TSX VENTURE:ANF) announces that at its Special and Annual General Meeting of Shareholders held on June 12, 2014, its shareholders voted 99.9% in favour of the transaction previously announced on April 24, 2014 (the "Transaction"). If the Transaction is completed, it will result in the sale of Anfield's Guatemalan subsidiary, Mayaniquel S.A. and its Mayaniquel nickel laterite project (which is a sale of substantially all of the assets of Anfield) to Cunico Resources N.V. ("Cunico"). The Transaction is expected to close shortly, subject to the remaining conditions set out in the share purchase agreement dated April 23, 2014 between Anfield and Cunico (the "Share Purchase Agreement").
Full details of the Transaction are included in the Share Purchase Agreement, information circular dated May 9, 2014 and certain related documents and agreements all of which are available for review on SEDAR (www.sedar.com).
Anfield Nickel Corp.
Signed: "David Strang"
David Strang, Chairman
CAUTION REGARDING FORWARD LOOKING STATEMENTS: Information and statements contained in this news release that are not historical facts are "forward-looking information" or "forward-looking statements" within the meaning of applicable Canadian securities legislation and the United States Private Securities Litigation Reform Act of 1995, respectively, and involve risks and uncertainties. Examples of forward-looking information and statements contained in this news release include information and statements with respect to:
the timing and completion of Anfield's sale of Mayaniquel S.A. to Cunico; and
the receipt of regulatory and other approvals for Anfield's sale of Mayaniquel S.A. to Cunico.
In certain cases, forward-looking information can be identified by the use of words such as "is expected", "proposed" or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions, events or results, "may", "would", "will be" or "shall" be taken, occur or be achieved.
Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information and statements. In some instances, material assumptions and factors are presented or discussed in this news release in connection with the statements or disclosure containing the forward-looking information and statements. You are cautioned that the following list of material factors and assumptions is not exhaustive. The factors and assumptions include, but are not limited to, assumptions concerning: the receipt of regulatory and other approvals for Anfield's sale of Mayaniquel, S.A. to Cunico and closing conditions to the sale of Mayaniquel S.A. to Cunico being met.
Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ materially from those expressed or implied by the forward-looking statements, including, without limitation risks that closing conditions to the sale of Mayaniquel S.A. to Cunico are not met.
This list is not exhaustive of the factors that may affect the forward-looking information and statements contained in this news release. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the forward-looking information and statements. The forward-looking information and statements contained in this news release are based on beliefs, expectations and opinions as of the date of this news release. For the reasons set forth above, readers are cautioned not to place undue reliance on forward-looking information. Anfield does not undertake to update any forward-looking information and statements included herein, except in accordance with applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
